IP Library Granted Patent US 8,785,627
Granted Patent B2
US 8,785,627 · App. 13/959,404 · Granted Jul 22, 2014

Copolymerizable methine and anthraquinone compounds and articles containing them

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,785,627
App. No.
13/959,404
Granted
Jul 22, 2014
Kind
B2
Abstract

This invention relates to polymerizable ultraviolet light absorbers and yellow colorants and their use in ophthalmic lenses. In particular, this invention relates to polymerizable ultraviolet light absorbing methane compounds and yellow compounds of the methine and anthraquinone classes that block ultraviolet light and/or violet-blue light transmission through ophthalmic lenses.

Claims (89)

1. A compound having the molecular structure of Formula II:

wherein:

R and R 1 are independently selected from C 1 -C 12 -alkyl, substituted C 1 -C 12 -alkyl, aryl, heteroaryl, C 3 -C 8 -cycloalkyl, C 3 -C 8 -alkenyl, —(CHR′CHR″O—) n —R 4 , C 1 -C 6 -alkylsulfonyl, arylsulfonyl, C 1 -C 12 -acyl, substituted-C 1 -C 12 -acyl, -L-Q and -Q; or R and R 1 are combined to make phthalimido, succinimido, morpholino, thiomorpholino, pyrrolidino, piperidino, piperazino, or thiomorpholino-S,S-dioxide;

R 2 is selected from hydrogen or one or two groups selected from hydroxy, C 1 -C 6 alkyl, C 1 -C 6 alkoxy and halogen;

X 1 is selected from cyano, —CO 2 —C 1 -C 6 -alkyl, C 1 -C 6 -alkylsulfonyl, arylsulfonyl, carbamoyl, C 1 -C 6 -alkanoyl, aroyl, aryl, heteroaryl and —COY;

X 2 is —COY or carbamoyl;

R′ and R″ are independently selected from hydrogen and C 1 -C 12 -alkyl;

Y is selected from —NR′-L-Q, and —N-(L-Q) 2 ;

L is a divalent organic radical selected from C 1 -C 6 -alkylene-O—, C 1 -C 6 -alkylene-NR′—; arylene-C 1 -C 6 -alkylene-O—, arylene-C 1 -C 6 -alkylene-NR′—, arylene-O(CHR′CHR″O) n —, C 1 -C 6 -alkylene-Y 1 —(CHR′CHR″O—) n —, and —(CHR′CHR″O—) n —;

Y 1 is selected from —O—, —S—, —SO 2 —, —N(SO 2 R 5 )—, and —N(COR 5 )—;

R 4 is selected from hydrogen, C 1 -C 12 -alkyl, C 1 -C 6 -alkanoyl and aryl;

R 5 is C 1 -C 12 -alkyl, substituted C 1 -C 12 -alkyl, C 3 -C 8 -cycloalkyl or aryl;

n is an integer from 1 to 100;

Q is:

wherein:

R 6 is hydrogen or C 1 -C 6 -alkyl;

R 7 is: hydrogen; C 1 -C 6 alkyl; phenyl; phenyl substituted with one or more groups selected from C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, —N(C 1 -C 6 -alkyl) 2 , nitro, cyano, C 1 -C 6 -alkoxycarbonyl, C 1 -C 6 -alkanoyloxy and halogen; 1- or 2-naphthyl; 1- or 2-naphthyl substituted with C 1 -C 6 -alkyl or C 1 -C 6 -alkoxy; 2- or 3-thienyl; 2- or 3-thienyl substituted with C 1 -C 6 -alkyl or halogen; 2- or 3-furyl; or 2- or 3-furyl substituted with C 1 -C 6 -alkyl;

R 8 and R 9 are, independently, hydrogen, C 1 -C 6 -alkyl, or aryl; or R 8 and R 9 are combined to represent a CH 2 3-5 radical;

R 10 is hydrogen, C 1 -C 6 -alkyl, C 1 -C 8 -alkenyl, C 3 -C 8 -cycloalkyl or aryl; and

R 11 is hydrogen, C 1 -C 6 -alkyl or aryl; and

the compound comprises at least one Q group.

2. The compound of claim 1 , wherein:

R and R 1 are independently selected from C 1 -C 12 -alkyl, substituted C 1 -C 12 -alkyl, and aryl; or R and R 1 are combined to make cyclic structures such as phthalimido, succinimido, morpholino, thiomorpholino, pyrrolidino, piperidino, piperazino, or thiomorpholino-S,S-dioxide;

R 2 is selected from hydrogen, C 1 -C 6 alkyl and halogen;

X 1 is cyano;

X 2 is —COY;

Y is selected from —NR′-L-Q, and —N-(L-Q) 2 ;

R′ is selected from hydrogen and C 1 -C 12 -alkyl;

L is C 1 -C 6 -alkylene-O; and

Q is:

wherein R 6 is hydrogen or methyl, R 7 is hydrogen and R 8 and R 9 are methyl.

3. The compound of claim 1 , wherein:

R and R 1 are independently selected from C 1 -C 12 -alkyl, substituted C 1 -C 12 -alkyl, aryl, heteroaryl, C 3 -C 8 -cycloalkyl, C 3 -C 8 -alkenyl, —(CHR′CHR″O—) n —, C 1 -C 6 -alkylsulfonyl, arylsulfonyl, C 1 -C 12 -acyl, substituted-C 1 -C 12 -acyl, -L-Q and -Q; or R and R 1 are combined to make phthalimido, succinimido, morpholino, thiomorpholino, pyrrolidino, piperidino, piperazino, or thiomorpholino-S,S-dioxide;

R 2 is hydrogen;

X 1 is cyano;

X 2 is —COY;

Y is selected from —NR′-L-Q, —N-(L-Q) 2 ;

R′ is hydrogen;

L is selected from —CH 2 CH 2 —O—, —CH 2 CH(CH 3 )—O—;

n is an integer selected from 1 to 3; and

Q is —C(O)C(R 6 )═CHR 7 , wherein R 6 is methyl and R 7 is hydrogen.

4. The compound of claim 1 , wherein:

R and R 1 are independently selected from methyl, ethyl, —CH 2 CH 2 CN, —CH 2 CH 2 OCOCH 3 ; —CH 2 CH(CH 3 )OCOCH 3 ; or R and R 1 are combined to make thiomorpholino-S,S-dioxide;

R 2 is hydrogen;

X 1 is cyano;

X 2 is —COY;

Y is selected from —NR′-L-Q, and —N-(L-Q) 2 ;

R′ is hydrogen;

L is selected from —CH 2 CH 2 —O—, and —CH 2 CH(CH 3 )—O—; and

Q is —C(O)C(R 6 )═CHR 7 , wherein R 6 is methyl and R 7 is hydrogen.

5. The compound of claim 1 , wherein:

R and R 1 combined to make thiomorpholino-S,S-dioxide;

R 2 is hydrogen;

X 1 is cyano;

X 2 is —COY;

Y is —NR′-L-Q;

R′ is hydrogen;

L is —CH 2 CH(CH 3 )—O—; and

Q is —C(O)C(R 6 )═CHR 7 , wherein R 6 is methyl and R 7 is hydrogen.

6. The compound of claim 1 , wherein:

R and R 1 are independently selected from —CH 2 CH 2 CN, —CH 2 CH 2 Cl, —CH 2 CH 2 —OCO—C 1 -C 4 -alkyl, —CH 2 CH 2 OCO-aryl, —CH 2 CH 2 —OC(O)NH-aryl,

—C 1 -C 4 -alkyl, and —CH 2 C 6 H 4 CO 2 —C 1 -C 4 -alkyl; or R and R 1 are combined to make the cyclic structure thiomorpholino-S,S-dioxide;

Y is —NH-L-Q;

L is —CH 2 CH 2 O—, —CH 2 CH(CH 3 )O—, —(CH 2 ) 3 O—, —(CH 2 ) 4 O—, —(CH 2 ) 6 O—, —CH 2 C(CH 3 ) 2 CH 2 O—, —CH 2 —C 6 H 10 —CH 2 O—, —C 6 H 4 —CH 2 CH 2 O—, —C 6 H 4 —OCH 2 CH 2 O—, or —CH 2 CH 2 (OCH 2 CH 2 ) 1-3 O—, and

Q is

wherein R 6 is methyl; R 8 and R 9 are methyl.

7. The compound of claim 1 , wherein:

R and R 1 are independently selected from —CH 2 CH 2 CN, —CH 2 CH 2 Cl, —CH 2 CH 2 —OCO—C 1 -C 4 -alkyl, —CH 2 CH 2 OCO-aryl, —CH 2 CH 2 —OC(O)NH-aryl,

—C 1 -C 4 -alkyl, and —CH 2 C 6 H 4 CO 2 —C 1 -C 4 -alkyl; or R and R 1 are combined to make the cyclic structure thiomorpholino-S,S-dioxide;

Y is —NH-L-Q;

L is —CH 2 CH 2 O—, —CH 2 CH(CH 3 )O, —(CH 2 ) 3 O—, —(CH 2 ) 4 O—, —(CH 2 ) 6 O—, —CH 2 C(CH 3 ) 2 CH 2 O—, —CH 2 —C 6 H 10 —CH 2 O—, —C 6 H 4 —CH 2 CH 2 O—, —C 6 H 4 —OCH 2 CH 2 O—, or —CH 2 CH 2 (OCH 2 CH 2 ) 1-3 O—; and

Q is —C(O)C(R 6 )═CHR 7

wherein R 6 is methyl; and R 7 is hydrogen.

8. The compound of claim 1 , wherein:

R is —CH 2 CH 2 CN;

R 1 is —CH 2 CH 2 CN, —CH 2 CH 2 Cl, —CH 2 CH 2 OCO—C 1 -C 4 -alkyl,

Y is —NH-L-Q;

L is —CH 2 CH 2 O— or —CH 2 CH(CH 3 )O—; and

Q is

wherein R 6 , R 8 and R 9 are methyl.

9. The compound of claim 1 , wherein:

R is —CH 2 CH 2 CN;

R 1 is —CH 2 CH 2 CN, —CH 2 CH 2 Cl, —CH 2 CH 2 OCO—C 1 -C 4 -alkyl,

Y is —NH-L-Q;

L is —CH 2 CH 2 O— or —CH 2 CH(CH 3 )O—; and

Q is —C(O)C(R 6 )═CHR 7 ;

R 6 is methyl; and

R 7 is hydrogen.

10. A compound comprising a molecular structure depicted by Formula VII:

Assignments (4)
CHANGE OF NAME Recorded Sep 25, 2018
From: ABBOTT MEDICAL OPTICS INC.
To: JOHNSON & JOHNSON SURGICAL VISION, INC.
Reel/Frame 047150/0976 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2014
From: PEARSON, JASON CLAY; WEAVER, MAX ALLEN; FLEISCHER, JEAN CARROLL; KING, GREG ALAN
To: EASTMAN CHEMICAL COMPANY
Reel/Frame 032012/0286 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2014
From: EASTMAN CHEMICAL COMPANY
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 032012/0316 →
MERGER Recorded Jan 21, 2014
From: ADVANCED MEDICAL OPTICS, INC.
To: ABBOTT MEDICAL OPTICS INC.
Reel/Frame 032012/0336 →